These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 22187927)
1. [Cancer screening programme in health care workers]. Pisati G; Cerri S; Marinelli M; Tedeschi B; Valsecchi E G Ital Med Lav Ergon; 2011; 33(2 Suppl):57-60. PubMed ID: 22187927 [TBL] [Abstract][Full Text] [Related]
2. Use of cancer screening services in Greece and associated social factors: results from the nation-wide Hellas Health I survey. Dimitrakaki C; Boulamatsis D; Mariolis A; Kontodimopoulos N; Niakas D; Tountas Y Eur J Cancer Prev; 2009 Jun; 18(3):248-57. PubMed ID: 19491613 [TBL] [Abstract][Full Text] [Related]
3. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening? Carlos RC; Fendrick AM; Ellis J; Bernstein SJ J Am Coll Radiol; 2004 Oct; 1(10):769-76. PubMed ID: 17411698 [TBL] [Abstract][Full Text] [Related]
5. The diffusion of screening programmes in Italy, year 2009. Zappa M; Dardanoni G; Giorgi Rossi P; Grazzini G; Naldoni C; Paci E; Pirola ME; Pizzuti R; Segnan N; Zorzi M; Federici A Epidemiol Prev; 2011; 35(5-6 Suppl 5):3-7. PubMed ID: 22166346 [TBL] [Abstract][Full Text] [Related]
6. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017. Hristova L; Hakama M Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316 [TBL] [Abstract][Full Text] [Related]
7. Cancer screening uptake: association with individual characteristics, geographic distribution, and time trends in Italy. Carrozzi G; Sampaolo L; Bolognesi L; Sardonini L; Bertozzi N; Giorgi Rossi P; Zappa M; Baldissera S; Campostrini S; Ferrante G; Masocco M; Minardi V; D'Argenzio A; Moghadam PF; Quarchioni E; Ramigni M; Trinito MO; Salmaso S; Epidemiol Prev; 2015; 39(3 Suppl 1):9-18. PubMed ID: 26405772 [TBL] [Abstract][Full Text] [Related]
8. Cancer screening in Singapore, with particular reference to breast, cervical and colorectal cancer screening. Yeoh KG; Chew L; Wang SC J Med Screen; 2006; 13 Suppl 1():S14-9. PubMed ID: 17227636 [TBL] [Abstract][Full Text] [Related]
9. [Responsible cancer screening]. Verbeek AL; van Dijck JA; Kiemeney LA; Broeders MJ Ned Tijdschr Geneeskd; 2011; 155(45):A3934. PubMed ID: 22085573 [TBL] [Abstract][Full Text] [Related]
10. [Cancer screening programmes in Italy: unification element or factor for further division?]. Zappa M; Federici A; Salmaso S Epidemiol Prev; 2011; 35(5-6 Suppl 2):100-2. PubMed ID: 22166878 [No Abstract] [Full Text] [Related]
11. Evaluation of a combined screening programme for breast, cervical and colorectal cancers in France. Billette de Villemeur A; Exbrayat C; Garnier A; Ancelle-Park R; Ferley JP; Jestin C Eur J Cancer Prev; 2007 Feb; 16(1):26-35. PubMed ID: 17220701 [TBL] [Abstract][Full Text] [Related]
12. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women. Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228 [TBL] [Abstract][Full Text] [Related]
13. The importance of socio-economic variables in cancer screening participation: a comparison between population-based and opportunistic screening in the EU-15. Walsh B; Silles M; O'Neill C Health Policy; 2011 Aug; 101(3):269-76. PubMed ID: 21420755 [TBL] [Abstract][Full Text] [Related]
14. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer. Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181 [TBL] [Abstract][Full Text] [Related]
15. Colonoscopy surveillance in asymptomatic subjects with increased risk for colorectal cancer: clinical evaluation and cost analysis of an Italian experience. Matarese VG; Feo CV; Pezzoli A; Trevisani L; Brancaleoni M; Gullini S Eur J Cancer Prev; 2007 Aug; 16(4):292-7. PubMed ID: 17554201 [TBL] [Abstract][Full Text] [Related]
16. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group. Lynge E APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674 [TBL] [Abstract][Full Text] [Related]
17. Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence. Grazzini G; Ciatto S; Cislaghi C; Castiglione G; Falcone M; Mantellini P; Zappa M; J Med Screen; 2008; 15(4):175-81. PubMed ID: 19106257 [TBL] [Abstract][Full Text] [Related]
18. Evolution of multiple disease screening in Keelung: a model for community involvement in health interventions? Wang PE; Wang TT; Chiu YH; Yen AM; Chen TH J Med Screen; 2006; 13 Suppl 1():S54-8. PubMed ID: 17227644 [TBL] [Abstract][Full Text] [Related]
19. Round one of the Adelaide and Meath Hospital/Trinity College Colorectal Cancer Screening Programme: programme report and analysis based on established international key performance indices. McNamara D; Qasim A; Lee N; Condon C; O'Morain C Ir J Med Sci; 2011 Jun; 180(2):549-52. PubMed ID: 21264524 [TBL] [Abstract][Full Text] [Related]
20. Patient Navigation for Comprehensive Cancer Screening in High-Risk Patients Using a Population-Based Health Information Technology System: A Randomized Clinical Trial. Percac-Lima S; Ashburner JM; Zai AH; Chang Y; Oo SA; Guimaraes E; Atlas SJ JAMA Intern Med; 2016 Jul; 176(7):930-7. PubMed ID: 27273602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]